Skip to main content

Table 5 ASA Desensitization

From: A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma

Total desensitized (n = 111)

Treatment during desensitization (n, %)

  Yes

39 (35.1)

  No

66 (59.5)

  Unknown

6 (5.4)

Treatment medication (n)

  Nasal Steroid

2

  Oral Steroid

21

  Puffer (SABA, ICS, combination)

13

  Epinephrine

1

Patient improvement on ASA (n, %)

  Yes

81 (73.0)

  No

23 (20.7)

  Unknown

7 (6.3)

Patient improvement score (out of 3)

  Change in taste or smell (1 pt)

34/111

  Change in upper respiratory symptoms (1 pt)

78/111

  Change in lower respiratory symptoms (1 pt)

67/111

0 out of 3

17 (15.3)

1 out of 3

20 (18.1)

2 out of 3

45 (40.5)

3 out of 3

24 (21.6)

Unknown

5 (4.5)